Dioseve
Develops iPS cell-derived co-culture technology to improve oocyte maturation and reduce IVF treatment burden
$7MSeries A+
Role not disclosedMD
Mirai Door (Asuka Innovation Fund)
Activity from announced rounds
Activity in this selectionroland-peralta-e7a56f0a
- Rounds participated in
- 1
- Confirmed lead rounds
- — 1 roles undisclosed
- New companies
- 1 First participation on record · 0 follow-on
- Funding in participating rounds
- $7M 1 disclosed · full round size, not this investor’s share